To include your compound in the COVID-19 Resource Center, submit it here.

Abasria insulin glargine regulatory update

The European Commission approved Abasria insulin glargine from Eli Lilly and Boehringer to treat Type I and II diabetes. The basal insulin glargine

Read the full 230 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE